Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor
- 1 February 1998
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 37 (2) , 107-120
- https://doi.org/10.1016/s0166-3542(97)00065-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- In vitro activity of the neuraminidase inhibitor GS4071 against influenza viruses: FG Hayden and BS Rollins, University of Virginia, Charlottesville, Virginia, USAAntiviral Research, 1997
- GS 4071 is a potent and selective inhibitor of the growth and neuraminidase activity of influenza A and B viruses in vitroAntiviral Research, 1997
- GS 4104 is a highly bioavailable prodrug of the novel, potent influenza neuraminidase inhibitor GS 4071Antiviral Research, 1997
- Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epitheliumAntiviral Research, 1994
- Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acidAntiviral Research, 1994
- Rational design of potent sialidase-based inhibitors of influenza virus replicationNature, 1993
- Clinical and epidemiological importance of influenza a viruses resistant to amantadine and rimantadineReviews in Medical Virology, 1992
- Prophylaxis and Treatment of InfluenzaNew England Journal of Medicine, 1990
- Effect of selenazofurin on influenza A and B virus infections of miceAntiviral Research, 1986
- Inhibition of Influenza Virus Replication in Tissue Culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): Mechanism of ActionJournal of General Virology, 1976